7 News & Press Releases found
Graftys News
-
Graftys Announces New Manufacturing & Logistic Site in Liège (Belgium)
GRAFTYS SA (“Graftys”), a global leader in resorbable bone cements, announces today the opening of its new preparation and logistic site in Liège (Belgium). Continuously strengthening its manufacturing capability and reinforcing ...
-
Graftys And Its Partner Las Brasil Cross The Milestone Of 10,000 Graftys® Hbs Units Sold In Brazil
GRAFTYS SA (“Graftys”), a global leader in resorbable bone cements, is proud to announce that as a fruitful result of 10 years’ partnership with its distributor - LAS Brasil, the milestone of 10,000 units of GRAFTYS® HBS sold ...
-
Graftys Achieves Ce Recertification And Mdsap Certification For Australia, Brazil, Canada And Usa
GRAFTYS SA (“Graftys”), a global leader in resorbable bone cements, is pleased to announce the CE recertification in Europe and the certification of its Quality Management System in conformity with the Medical Device Single Audit Program ...
-
Graftys adds a new distribution partnership in the US territory
GRAFTYS SA (“Graftys”), a global leader in resorbable bone cements, today announces a new distribution agreement for its bestselling product Graftys® QuickSet in the US territory. Responding to a medical need and to a direct request ...
-
Graftys Strengthens Its Management And Operations
Graftys, a French Société Anonyme specialized in the development, manufacturing and commercialization of synthetic orthopedic biomaterials, announced today the appointment of its Chairman of the Board, Gilles Alberici, as Chief ...
-
Graftys Announces Creation of an International Implant Registry to Follow up Graftys® HBS and Graftys® QuickSet
Aix-en-Provence, November 16th, 2015 – GRAFTYS SA, a company which develops and commercializes biomaterials used in orthopedic surgery, announces that it has recently established an ambitious Post Marketing Surveillance program, in the form of ...
-
GRAFTYS announces the extension of its CE mark for its calcium phosphate cements to now include GRAFTYS® HBS and GRAFTYS® Quickset for the indication of subchondral bone marrow lesions around the knee joint (BML)
Aix-en-Provence, September 14th, 2015 – GRAFTYS SA, a company focused on development and commercialization of orthopedic biomaterials, is pleased to announce that it has obtained authorization from its notified body, NSAI (National Standards ...